Lyme disease is a complex, multi-systemic infection caused by Borrelia burgdorferi spirochetes. While ticks are the most well-known vector, transmission can occur through multiple pathways. When left untreated or inadequately treated, it can become a debilitating chronic illness affecting virtually every organ system.
Lyme disease presents with a wide range of symptoms that can mimic dozens of other conditions. The classic erythema migrans (bull’s-eye rash) appears in only 50-70% of cases, meaning many patients never receive the early warning sign that could lead to prompt treatment.
Symptoms typically develop in stages, but in chronic Lyme disease, multiple symptom clusters often overlap simultaneously:
While ticks are the most well-known vector for Lyme disease, Borrelia burgdorferi and related species can be transmitted through multiple pathways. Understanding all potential routes of infection is essential for accurate diagnosis and family screening.
The most documented route of transmission. Ixodes ticks (deer ticks) carry Borrelia in their gut and transmit the spirochetes during feeding. Nymphal ticks are particularly dangerous due to their small size, which makes them difficult to detect.
Borrelia can cross the placental barrier. Maternal-fetal transmission has been documented in medical literature, making prenatal screening important for infected mothers. This pathway is well-established and should be considered in the care of pregnant patients with known Borrelia infection.
Emerging research suggests that mosquitoes may serve as mechanical vectors for Borrelia transmission. While less well-documented than tick-borne transmission, this pathway warrants clinical consideration.
While not conclusively established in controlled studies, clinical observations at St. George Hospital and elsewhere have documented whole families with multiple members infected with Borrelia. These patterns raise important questions about person-to-person transmission that remain an active area of investigation.
Horse flies are known to carry Borrelia and may transmit the spirochetes during blood feeding. Their aggressive biting behavior and large mouthparts may facilitate transmission.
At St. George Hospital, we have treated families where multiple members — parents and children — are infected with Borrelia. While tick exposure remains the primary documented route, clinicians should consider all potential vectors when evaluating patients with unexplained multi-member family infections.
Standard Lyme testing has significant limitations that leave millions of patients without answers. Understanding these gaps is the first step toward getting proper care.
The two-tier testing system (ELISA followed by Western Blot) recommended by the CDC has a sensitivity of only 50-60% for chronic Lyme disease. Many patients with active infection receive negative results because these tests measure antibody response, not the presence of the bacteria itself. In late-stage disease, immune suppression can further reduce antibody production, making false negatives even more likely.
Lyme disease has been called "the great imitator" because its symptoms overlap with fibromyalgia, chronic fatigue syndrome, multiple sclerosis, rheumatoid arthritis, lupus, depression, and many other conditions. Patients are frequently diagnosed with these conditions and treated symptomatically for years without anyone investigating an underlying infectious cause.
A long-standing divide exists in the medical community between those who acknowledge chronic Lyme disease as a persistent infection and those who attribute ongoing symptoms to a post-infectious autoimmune response. This controversy means that many physicians dismiss patients who have completed standard antibiotic courses but continue to experience disabling symptoms.
Borrelia burgdorferi is one of the most sophisticated pathogens in nature. Unlike many bacteria, it has evolved multiple mechanisms to evade the immune system and resist antibiotic treatment.
Borrelia spirochetes can alter their outer surface proteins to avoid immune detection, a process called antigenic variation. They can also suppress key immune pathways, reducing the body's ability to mount an effective response. This immune suppression is one reason why antibody-based tests often fail in chronic infection.
Borrelia can form biofilms, protective communities of bacteria encased in a polysaccharide matrix that shields them from both antibiotics and the immune system. Biofilm-associated bacteria can be up to 1,000 times more resistant to antibiotics than free-swimming spirochetes.
Research has demonstrated that Borrelia can persist in deep tissues, including joints, the nervous system, and the heart, even after antibiotic treatment. The spirochetes can convert into metabolically inactive "round body" or cyst forms that are resistant to standard antibiotics and can revert to active spirochetes when conditions become favorable.
Chronic Borrelia infection triggers a cascade of inflammatory cytokines that affect the brain, nervous system, joints, heart, and gut. This systemic inflammation is responsible for many of the symptoms patients experience, including fatigue, cognitive impairment, pain, and mood disturbances. Over time, this inflammatory state can become self-perpetuating, even if bacterial burden is reduced.
Borrelia can form biofilms, protective communities of bacteria encased in a polysaccharide matrix that shields them from both antibiotics and the immune system. Biofilm-associated bacteria can be up to 1,000 times more resistant to antibiotics than free-swimming spirochetes.
Given the complexity of chronic Lyme disease, a single-modality approach, whether antibiotics alone or alternative therapies alone, is rarely sufficient. At St. George Hospital, we have learned over four decades that the most effective strategy addresses every dimension of the illness simultaneously.
Our integrative approach targets:
Controlled elevation of core body temperature to 41.6-42.0 degrees Celsius. Borrelia spirochetes are heat-sensitive, and hyperthermia enhances immune function and antibiotic penetration into tissues.
IV and oral antibiotic protocols selected to target all morphological forms of Borrelia, including spirochetes, round bodies, and biofilm communities, as well as specific co-infections.
Blood filtration therapy that removes inflammatory proteins, immune complexes, toxins, and infection-related debris from the bloodstream, reducing systemic inflammation rapidly.
Therapies to restore balanced immune function, including thymus peptides, micronutrient infusions, and immune-stimulating protocols to support the body's natural defense against Borrelia.
Comprehensive detox protocols to manage Herxheimer reactions and reduce the burden of endotoxins released during bacterial die-off, including IV glutathione, liver support, and binder protocols.
Physical therapy, psychotherapy, nutritional support, and pain management to address the full impact of chronic Lyme disease on quality of life and support recovery.
The existence of persistent Borrelia infection after antibiotic treatment has been demonstrated in numerous peer-reviewed studies. Research published in journals including the New England Journal of Medicine, PLOS ONE, and Frontiers in Medicine has confirmed that Borrelia can survive standard antibiotic therapy through morphological variation, biofilm formation, and intracellular persistence.
Studies on whole-body hyperthermia for Borrelia infection have shown that elevated temperatures significantly reduce spirochete viability and enhance the effectiveness of concurrent antibiotic therapy. Our own clinical observations over more than 40 years and thousands of patients support the efficacy of this multimodal approach.
While large-scale randomized controlled trials specific to our combined protocol remain limited, as is common in integrative medicine, the individual components of our approach are each supported by published evidence. We maintain rigorous internal outcome tracking and continue to refine our protocols based on clinical results.
Our diagnostic team can help determine whether Lyme disease or co-infections may be driving your symptoms. Contact us to discuss your case.
